• Skip to main content
  • Skip to primary sidebar
Transfusion News
  • About Us
  • Topics
    • Adverse Events (non-infectious)
    • Blood Donation
    • Cell Therapy
    • Coagulation & Plasma Transfusion
    • Platelet Transfusion
    • Policy and Guidelines
    • Quality Control and Regulatory
    • RBC Transfusion
    • Serology/Genotyping
    • Special Transfusion Situations
    • Transfusion Transmitted Infections
  • Continuing Education
  • Archives
  • Podcasts
  • Question of the Day
  • Search
  • Subscribe to Email Alerts
  • Follow us on
  • Search
  • Subscribe to Email Alerts

Archive by Topic » News

Minimal Concerns for HIV in the US Blood Supply after FDA Revised Guidance

In 2015, the U.S. FDA revised guidance for blood donor deferral of men who have sex with men (MSM) from…

September 15, 2020

NIH Urges Randomized Controlled Trials for COVID-19 Convalescent Plasma

On September 1, 2020, shortly after the U.S. Food and Drug’s Emergency Use Authorization (EUA) for the use of COVID-19…

September 9, 2020

High-throughput Blood Antigen Array Genotyping for Blood Donors

Alloimmunization to red blood cell (RBC), human leukocyte (HLA), and human platelet (HPA) antigens can lead to hemolytic transfusion reactions…

September 1, 2020

FDA Issues Emergency Use Authorization for COVID-19 Convalescent Plasma

To increase access to COVID-19 convalescent plasma (CCP) use, President Trump, in conjunction with the U.S. FDA, announced Emergency Use…

August 25, 2020

Restrictive Transfusion Strategies Safe for Extremely Low Birth-Weight Infants

Most extremely low birth-weight (ELBW) infants develop anemia, which can result in severe brain injury and/or impaired oxygen supply to…

August 19, 2020

Positive Coombs Tests and RBC Transfusions in Patients with COVID-19

During the early outbreak of SARS-CoV-2 in Italy, medical doctors and researchers observed a high frequency of positive direct antiglobulin…

August 12, 2020

Convalescent Plasma Is Safe and Likely Efficacious for Patients with COVID-19

There are limited therapeutic options to treat COVID-19, and COVID-19 convalescent plasma (CCP) is currently one of the most common…

August 4, 2020

Studies Find Variable Anti-SARS-CoV-2 Antibody Responses

Three recent studies have analyzed anti-SARS-CoV-2 antibodies among individuals with asymptomatic and mild SARS-CoV-2 infections, and they have found that…

July 29, 2020

mRNA-1273 Vaccine Safe and Induces anti-SARS-CoV-2 Immune Responses

Using prior knowledge of the importance of the coronavirus spike proteins in pathogenesis and immunity as well as the SARS-CoV-2…

July 22, 2020

Practical Guidance for Blood Supply and Use during the COVID-19 Pandemic

Researchers in Europe and Canada reviewed more than 9,000 publications about COVID-19 and identified 414 papers relevant to blood collections,…

July 15, 2020

  • « Go to Previous Page
  • Page 1
  • Interim pages omitted …
  • Page 23
  • Page 24
  • Page 25
  • Page 26
  • Page 27
  • Interim pages omitted …
  • Page 61
  • Go to Next Page »

Primary Sidebar

Latest News

  • New Erythropoietin Gene Variants Linked to Hereditary Erythrocytosis

  • Multifaceted Threats to the Blood Supply from Climate Change

  • Distinct Roles for Differently Aged Platelets

  • Anemia Treatment Bundle Improves Hemoglobin Recovery after Critical Illness

    Question of the Day

    Copyright © 2025 John Wiley & Sons, Inc. All Rights Reserved.
    Privacy Policy

    Association for the Advancement of Blood and Biotherapies Wiley